[
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "Enzyme GIKS3 with a mass of 60 kDA must be phosphorylated at serine 25 to be active. Serine 25 is placed in the motif recognized by proteins from the calcium-dependent protein kinase family. Sequence analysis shows that proteins CaPK1, CaPK2, CaPK3, CaPK4, and CaPK5 have homology to calcium-dependent protein kinase. Masses of the kinases based on the sequence analysis are as follows: CaPK1 \u2013 45 kDA, CaPK2 \u2013 102 kDA, CaPK3 65kDA, CaPK4 55 kDA, and CaPK5 \u2013 39 kDA.\nThe researchers decided to test if they could use the five potential kinases to activate the enzyme GIKS3.\nIn the first experiment, they performed size-exclusion chromatography coupled to the multi-angle light scattering (SEC-MALS) to check if the kinases can interact with GIKS3. The equal molar amounts of the proteins were mixed and after 60 minutes of incubation, the samples were analyzed with SEC-MALS. The results of the analysis are shown below. Masses of the kinases based on the sequence analysis: CaPK1 \u2013 45 kDA, CaPK2 \u2013 102 kDA, CaPK3 65 kDA, CaPK4 55 kDA, CaPK5 \u2013 39 kDA.\n\nGIKS3 alone control: peak corresponding to the protein with a mass of 120 kDa was detected.\nGIKS3+ CaPK1: peaks corresponding to protein with masses of 45 kDa, and 120 kDa were detected.\nGIKS3+ CaPK2: peak corresponding to protein with a mass of 222 kDa was detected.\nGIKS3+ CaPK3: peaks corresponding to proteins with masses of 65 kDa, 120 kDa, and 185 kDa were detected. \nGIKS3+ CaPK4: peaks corresponding to proteins with masses of 55 kDA, and 120 kDa were detected.\nGIKS3+ CaPK5: peaks corresponding to protein with masses of 39 kDA, 120 kDA, and 159 kDa were detected.\n\nIn the next experiment the researchers decided to test if the selected kinases can phosphorylate GIK3 and GIKS wild0type variant where the serine 25 was substituted to alanine (GIKS3-S25A). During the experiment, the proteins were incubated in the buffer: 50 mM Tris-Cl, 150 mM NaCl, 10 mM MgCl2, 2 mM CaCl2, 50 \u03bcm ATP supplemented with 1.5 \u03bcCi of [\u03b3-32P]ATP. The samples were incubated for 30 minutes at 37C and then SDS-PAGE was performed. Next, the phosphorylated proteins were detected with autoradiography. The results are described below:\n\nGIKS3-wt alone: Any band was detected.\nGIKS3 -S25/A alone: Any band was detected.\n\nGIKS3-wt + CaPK1: band corresponding to the protein with a mass of 45 kDa was detected.\nGIKS3-S25/A + CaPK1: band corresponding to the protein with a mass of 45 kDa was detected.\n\nGIKS3-wt + CaPK2: bands corresponding to the proteins with a mass of 60 kDa and 102 kDa were detected.\nGIKS3-S25/A + CaPK2: bands corresponding to the proteins with a mass of 60 kDa and 102 kDa were detected.\n\nGIKS3-wt + CaPK3: bands corresponding to the proteins with a mass of 60 kDa and 65 kDa were detected.\nGIKS3-S25/A + CaPK3: band corresponding to the protein with a mass of 65 kDa was detected.\n\nGIKS3-wt + CaPK4: bands corresponding to the proteins with a mass of 55 kDa and 60 kDa were detected.\nGIKS3-S25/A + CaPK4: band corresponding to the protein with a mass of 55 kDa was detected.\n\nGIKS3-wt + CaPK5: Any band was detected.\nGIKS3-S25/A + CaPK5: Any band was detected.\n\nIn the last exams the GIKS3 was incubated with tested kinases in the buffer without radoactive ATP and the activity of the GIKS3 enzyme was tested by measuring the conversion of molecule A to molecule over 5 minutes. Based on the results the rate of conversion was calculated the results are provided below:\n\nGIKS3-wt alone: rate of conversion 0 mmol/min\nGIKS3 -S25/A alone: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK1: rate of conversion 0 mmol/min\nGIKS3-S25/A + CaPK1: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK2: rate of conversion 3 mmol/min\nGIKS3-S25/A + CaPK2: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK3: rate of conversion 3 mmol/min\nGIKS3-S25/A + CaPK3: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK4: rate of conversion 3 mmol/min\nGIKS3-S25/A + CaPK4: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK5: rate of conversion 0 mmol/min\nGIKS3-S25/A + CaPK5: rate of conversion 0 mmol/min\n\n\nBased on the provided data choose the correct answer:\n\nAnswer Choices:\nA. CaPK2 and CaPK3 can phosphorylate GIKS3 on serine 25. CaPK4 does not interact with GIKS3 and CaPK1 does not interact with GIKS3.\nB. Only CaPK3 and CaPK4 can activate GIKS3. The complex between CaPK4 and GIKS3 was not detected in the SEC-MALS experiment.\nC. None of the above is correct.\nD. CaPK2 CaPK3 can phosphorylate GIKS3 on serine 25. CaPK1 and CaPK4 do not interact with GIKS3.\nE. Only CaPK1, CaPK2, CaPK3 and CaPK4  are active kinases. CaPK2 and CaPK3 can phosphorylate GIKS3 on serine 25.\nF. Only CaPK3 and CaPK2 can phosphorylate GIKS3 on serine 25. CaPK4 does not interact with GIKS3 but CaPK1 interacts with GIKS3.\nG. Only CaPK3 and CaPK4 can activate GIKS3. Only CaPK2 interacts with GIKS3.\nH. Only CaPK3 and CaPK4 can activate GIKS3. The complex between CaPK4 and GIKS3 was detected in the SEC-MALS experiment.\nI. Only CaPK2 and CaPK3 can phosphorylate GIKS3 on serine 25."
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H",
                  "I"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762211263-YSZ5DjELRyGzruz6EbRH",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"C\\n\\nReasoning (summary):\\n- SEC-MALS: CaPK2, CaPK3 and CaPK5 form complexes with GIKS3 (peaks at 222, 185 and 159 kDa respectively). CaPK1 and CaPK4 show only separate peaks (no stable complex detected by SEC-MALS).\\n- Autoradiography (32P): CaPK1 and CaPK2 autophosphorylate; CaPK2 and CaPK3 phosphorylate GIKS3-wt. For specificity: CaPK3 and CaPK4 phosphorylate GIKS3 only when S25 is present (GIKS3-S25A abolishes the 60 kDa signal with these kinases), whereas CaPK2 still labels the S25A mutant (so CaPK2 phosphorylates additional site(s) on GIKS3 as well).\\n- Activity assay: GIKS3 is activated (3 mmol/min) only when incubated with CaPK2, CaPK3 or CaPK4, and activation is lost with the S25A mutant \u2014 indicating S25 phosphorylation is required for activation and that CaPK2, CaPK3 and CaPK4 can produce that activating modification (even though CaPK2 also phosphorylates other sites and CaPK4\u2019s stable complex was not detected by SEC-MALS).\\n\\nNo answer choice correctly reflects all three datasets (interaction by SEC-MALS, phosphorylation specificity by autoradiography, and activity), so the correct choice is C.\",\"answer_letter\":\"C\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": null,
            "reasoning_details": [
              {
                "type": "reasoning.encrypted",
                "data": "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",
                "id": "rs_0acbc319190aef2f01690935c006f08190a73394be0ff2744f",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762211263,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 3016,
        "prompt_tokens": 1591,
        "total_tokens": 4607,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 2688,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 1536
        },
        "cost": 0.00608415,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 5.215e-05,
          "upstream_inference_completions_cost": 0.006032
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "Enzyme GIKS3 with a mass of 60 kDA must be phosphorylated at serine 25 to be active. Serine 25 is placed in the motif recognized by proteins from the calcium-dependent protein kinase family. Sequence analysis shows that proteins CaPK1, CaPK2, CaPK3, CaPK4, and CaPK5 have homology to calcium-dependent protein kinase. Masses of the kinases based on the sequence analysis are as follows: CaPK1 \u2013 45 kDA, CaPK2 \u2013 102 kDA, CaPK3 65kDA, CaPK4 55 kDA, and CaPK5 \u2013 39 kDA.\nThe researchers decided to test if they could use the five potential kinases to activate the enzyme GIKS3.\nIn the first experiment, they performed size-exclusion chromatography coupled to the multi-angle light scattering (SEC-MALS) to check if the kinases can interact with GIKS3. The equal molar amounts of the proteins were mixed and after 60 minutes of incubation, the samples were analyzed with SEC-MALS. The results of the analysis are shown below. Masses of the kinases based on the sequence analysis: CaPK1 \u2013 45 kDA, CaPK2 \u2013 102 kDA, CaPK3 65 kDA, CaPK4 55 kDA, CaPK5 \u2013 39 kDA.\n\nGIKS3 alone control: peak corresponding to the protein with a mass of 120 kDa was detected.\nGIKS3+ CaPK1: peaks corresponding to protein with masses of 45 kDa, and 120 kDa were detected.\nGIKS3+ CaPK2: peak corresponding to protein with a mass of 222 kDa was detected.\nGIKS3+ CaPK3: peaks corresponding to proteins with masses of 65 kDa, 120 kDa, and 185 kDa were detected. \nGIKS3+ CaPK4: peaks corresponding to proteins with masses of 55 kDA, and 120 kDa were detected.\nGIKS3+ CaPK5: peaks corresponding to protein with masses of 39 kDA, 120 kDA, and 159 kDa were detected.\n\nIn the next experiment the researchers decided to test if the selected kinases can phosphorylate GIK3 and GIKS wild0type variant where the serine 25 was substituted to alanine (GIKS3-S25A). During the experiment, the proteins were incubated in the buffer: 50 mM Tris-Cl, 150 mM NaCl, 10 mM MgCl2, 2 mM CaCl2, 50 \u03bcm ATP supplemented with 1.5 \u03bcCi of [\u03b3-32P]ATP. The samples were incubated for 30 minutes at 37C and then SDS-PAGE was performed. Next, the phosphorylated proteins were detected with autoradiography. The results are described below:\n\nGIKS3-wt alone: Any band was detected.\nGIKS3 -S25/A alone: Any band was detected.\n\nGIKS3-wt + CaPK1: band corresponding to the protein with a mass of 45 kDa was detected.\nGIKS3-S25/A + CaPK1: band corresponding to the protein with a mass of 45 kDa was detected.\n\nGIKS3-wt + CaPK2: bands corresponding to the proteins with a mass of 60 kDa and 102 kDa were detected.\nGIKS3-S25/A + CaPK2: bands corresponding to the proteins with a mass of 60 kDa and 102 kDa were detected.\n\nGIKS3-wt + CaPK3: bands corresponding to the proteins with a mass of 60 kDa and 65 kDa were detected.\nGIKS3-S25/A + CaPK3: band corresponding to the protein with a mass of 65 kDa was detected.\n\nGIKS3-wt + CaPK4: bands corresponding to the proteins with a mass of 55 kDa and 60 kDa were detected.\nGIKS3-S25/A + CaPK4: band corresponding to the protein with a mass of 55 kDa was detected.\n\nGIKS3-wt + CaPK5: Any band was detected.\nGIKS3-S25/A + CaPK5: Any band was detected.\n\nIn the last exams the GIKS3 was incubated with tested kinases in the buffer without radoactive ATP and the activity of the GIKS3 enzyme was tested by measuring the conversion of molecule A to molecule over 5 minutes. Based on the results the rate of conversion was calculated the results are provided below:\n\nGIKS3-wt alone: rate of conversion 0 mmol/min\nGIKS3 -S25/A alone: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK1: rate of conversion 0 mmol/min\nGIKS3-S25/A + CaPK1: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK2: rate of conversion 3 mmol/min\nGIKS3-S25/A + CaPK2: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK3: rate of conversion 3 mmol/min\nGIKS3-S25/A + CaPK3: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK4: rate of conversion 3 mmol/min\nGIKS3-S25/A + CaPK4: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK5: rate of conversion 0 mmol/min\nGIKS3-S25/A + CaPK5: rate of conversion 0 mmol/min\n\n\nBased on the provided data choose the correct answer:\n\nAnswer Choices:\nA. CaPK2 and CaPK3 can phosphorylate GIKS3 on serine 25. CaPK4 does not interact with GIKS3 and CaPK1 does not interact with GIKS3.\nB. Only CaPK3 and CaPK4 can activate GIKS3. The complex between CaPK4 and GIKS3 was not detected in the SEC-MALS experiment.\nC. None of the above is correct.\nD. CaPK2 CaPK3 can phosphorylate GIKS3 on serine 25. CaPK1 and CaPK4 do not interact with GIKS3.\nE. Only CaPK1, CaPK2, CaPK3 and CaPK4  are active kinases. CaPK2 and CaPK3 can phosphorylate GIKS3 on serine 25.\nF. Only CaPK3 and CaPK2 can phosphorylate GIKS3 on serine 25. CaPK4 does not interact with GIKS3 but CaPK1 interacts with GIKS3.\nG. Only CaPK3 and CaPK4 can activate GIKS3. Only CaPK2 interacts with GIKS3.\nH. Only CaPK3 and CaPK4 can activate GIKS3. The complex between CaPK4 and GIKS3 was detected in the SEC-MALS experiment.\nI. Only CaPK2 and CaPK3 can phosphorylate GIKS3 on serine 25."
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H",
                  "I"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762211263-FFc8oszzG91KVQ2B5O8R",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"C. None of the above is correct.\\n\\nReasoning (summary of evidence):\\n- SEC\u2011MALS: GIKS3 behaves as a 120 kDa species (dimer). Complexes detected: GIKS3+CaPK2 = 222 kDa (complex), GIKS3+CaPK3 = 185 kDa (complex) plus unbound proteins, GIKS3+CaPK5 = 159 kDa (complex). No complex peaks observed for CaPK1 or CaPK4 (only separate 45/120 and 55/120 peaks, respectively).\\n- Autoradiography (32P): CaPK1 and CaPK2, CaPK3, CaPK4 show kinase autophosphorylation. Phosphorylation of GIKS3 (60 kDa band) is seen with CaPK2, CaPK3 and CaPK4. For CaPK3 and CaPK4 the 60 kDa band disappears in the S25A mutant, indicating phosphorylation is on Ser25. For CaPK2 the 60 kDa band is present for both WT and S25A (so CaPK2 phosphorylates GIKS3 but also at sites other than S25; activity data shows it functionally requires S25 for activation of the enzyme).\\n- Activity assay: Only CaPK2, CaPK3 and CaPK4 activate GIKS3 (WT shows 3 mmol/min; S25A is inactive with each kinase), indicating phosphorylation at Ser25 is required for activation and that CaPK2/3/4 can phosphorylate that regulatory site (CaPK2 appears to phosphorylate additional sites as well). CaPK1 and CaPK5 do not activate GIKS3.\\n\\nTherefore the correct interpretation (CaPK2, CaPK3 and CaPK4 phosphorylate/activate GIKS3 at Ser25; CaPK1 autophosphorylates but does not phosphorylate/activate GIKS3; CaPK5 binds but does not phosphorylate/activate) is not listed among the answer choices, so C is correct.\",\"answer_letter\":\"C\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Interpreting data on protein interactions**\n\nI need to interpret the data carefully. First, SEC-MALS shows GIKS3 alone peaks at 120 kDa, indicating it's likely a dimer since it was initially given as 60 kDa. When analyzing mixtures, GIKS3 with CaPK1 shows separate peaks, indicating no interaction. However, GIKS3 and CaPK2 form a complex at 222 kDa. When paired with CaPK3, there are multiple peaks indicating partial binding. Finally, CaPK4 shows no interaction with GIKS3, while CaPK5 indicates a complex is present.**Analyzing kinase interactions with assays**\n\nIt looks like CaPK5 interacts, so I\u2019m moving to a kinase assay using gamma-32P for phosphorylation detection. The autoradiography shows that GIKS3-wildtype and mutant show no bands alone. When paired with CaPK1, a band at 45 kDa indicates autophosphorylation without phosphorylating GIKS3. With CaPK2, bands at 60 kDa and 102 kDa suggest GIKS3 is phosphorylated at a site other than S25. However, activation assays indicate CaPK2 activates wildtype but not S25A, suggesting S25 is critical for full activity.**Interpreting phosphorylation results**\n\nI noticed that both wildtype and S25A show a 60 kDa phospho-signal in the autoradiography, which complicates things. If S25 is essential, I\u2019d expect wildtype to have phosphorylation at that site, but S25A shouldn\u2019t show a band. Maybe that band corresponds to CaPK2 autophosphorylation instead? Nonetheless, it seems CaPK2 does phosphorylate both variants at other residues. The rates indicate that CaPK2 likely targets S25 in wildtype for activity, but also phosphorylates other sites in both. It suggests that other phosphorylation sites exist but don\u2019t activate the enzyme without S25.**Inferring phosphorylation by kinases**\n\nI need to gather evidence that CaPK2 phosphorylates S25. The activity increases for wildtype, but not for S25A, which strongly suggests that CaPK2 phosphorylates S25 in wildtype for activation. Even if CaPK2 targets other sites, activation hinges on S25. Moving on to CaPK3, the bands detected indicate that it also phosphorylates S25 since S25A loses the 60 kDa signal. Similarly, CaPK4 appears to phosphorylate S25, confirmed by activity rates and band presence in wildtype versus S25A. However, no complex formation between CaPK4 and GIKS3 suggests the phosphorylation might be transient or unstable.**Evaluating kinase interactions for GIKS3**\n\nIt seems that CaPK4 interacts functionally but doesn't form a stable complex, while CaPK5 shows no activity. CaPK1 autophosphorylates but doesn't phosphorylate GIKS3 or activate it. I see that CaPK2 can phosphorylate GIKS3, but not specifically S25, since it activates the wildtype while not affecting S25A. Upon reviewing options, I note that none accurately reflect the findings that CaPK2, CaPK3, and CaPK4 phosphorylate S25 and activate, while CaPK1 does not interact. So, I conclude that the correct answer is likely C: \"None of the above is correct.\" I\u2019ll support this by summarizing evidence from autoradiography, activity assays, and SEC-MALS interactions.",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Interpreting data on protein interactions**\n\nI need to interpret the data carefully. First, SEC-MALS shows GIKS3 alone peaks at 120 kDa, indicating it's likely a dimer since it was initially given as 60 kDa. When analyzing mixtures, GIKS3 with CaPK1 shows separate peaks, indicating no interaction. However, GIKS3 and CaPK2 form a complex at 222 kDa. When paired with CaPK3, there are multiple peaks indicating partial binding. Finally, CaPK4 shows no interaction with GIKS3, while CaPK5 indicates a complex is present.**Analyzing kinase interactions with assays**\n\nIt looks like CaPK5 interacts, so I\u2019m moving to a kinase assay using gamma-32P for phosphorylation detection. The autoradiography shows that GIKS3-wildtype and mutant show no bands alone. When paired with CaPK1, a band at 45 kDa indicates autophosphorylation without phosphorylating GIKS3. With CaPK2, bands at 60 kDa and 102 kDa suggest GIKS3 is phosphorylated at a site other than S25. However, activation assays indicate CaPK2 activates wildtype but not S25A, suggesting S25 is critical for full activity.**Interpreting phosphorylation results**\n\nI noticed that both wildtype and S25A show a 60 kDa phospho-signal in the autoradiography, which complicates things. If S25 is essential, I\u2019d expect wildtype to have phosphorylation at that site, but S25A shouldn\u2019t show a band. Maybe that band corresponds to CaPK2 autophosphorylation instead? Nonetheless, it seems CaPK2 does phosphorylate both variants at other residues. The rates indicate that CaPK2 likely targets S25 in wildtype for activity, but also phosphorylates other sites in both. It suggests that other phosphorylation sites exist but don\u2019t activate the enzyme without S25.**Inferring phosphorylation by kinases**\n\nI need to gather evidence that CaPK2 phosphorylates S25. The activity increases for wildtype, but not for S25A, which strongly suggests that CaPK2 phosphorylates S25 in wildtype for activation. Even if CaPK2 targets other sites, activation hinges on S25. Moving on to CaPK3, the bands detected indicate that it also phosphorylates S25 since S25A loses the 60 kDa signal. Similarly, CaPK4 appears to phosphorylate S25, confirmed by activity rates and band presence in wildtype versus S25A. However, no complex formation between CaPK4 and GIKS3 suggests the phosphorylation might be transient or unstable.**Evaluating kinase interactions for GIKS3**\n\nIt seems that CaPK4 interacts functionally but doesn't form a stable complex, while CaPK5 shows no activity. CaPK1 autophosphorylates but doesn't phosphorylate GIKS3 or activate it. I see that CaPK2 can phosphorylate GIKS3, but not specifically S25, since it activates the wildtype while not affecting S25A. Upon reviewing options, I note that none accurately reflect the findings that CaPK2, CaPK3, and CaPK4 phosphorylate S25 and activate, while CaPK1 does not interact. So, I conclude that the correct answer is likely C: \"None of the above is correct.\" I\u2019ll support this by summarizing evidence from autoradiography, activity assays, and SEC-MALS interactions.",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "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",
                "id": "rs_0ae461df4a2f464101690935c0018c819389dbdc57cadf5c9c",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762211263,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 2631,
        "prompt_tokens": 1591,
        "total_tokens": 4222,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 2176,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00565975,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.00039775,
          "upstream_inference_completions_cost": 0.005262
        }
      },
      "provider": "OpenAI"
    }
  },
  {
    "request": {
      "base_url": "https://openrouter.ai/api/v1",
      "model": "openai/gpt-5-mini",
      "messages": [
        {
          "role": "user",
          "content": "Enzyme GIKS3 with a mass of 60 kDA must be phosphorylated at serine 25 to be active. Serine 25 is placed in the motif recognized by proteins from the calcium-dependent protein kinase family. Sequence analysis shows that proteins CaPK1, CaPK2, CaPK3, CaPK4, and CaPK5 have homology to calcium-dependent protein kinase. Masses of the kinases based on the sequence analysis are as follows: CaPK1 \u2013 45 kDA, CaPK2 \u2013 102 kDA, CaPK3 65kDA, CaPK4 55 kDA, and CaPK5 \u2013 39 kDA.\nThe researchers decided to test if they could use the five potential kinases to activate the enzyme GIKS3.\nIn the first experiment, they performed size-exclusion chromatography coupled to the multi-angle light scattering (SEC-MALS) to check if the kinases can interact with GIKS3. The equal molar amounts of the proteins were mixed and after 60 minutes of incubation, the samples were analyzed with SEC-MALS. The results of the analysis are shown below. Masses of the kinases based on the sequence analysis: CaPK1 \u2013 45 kDA, CaPK2 \u2013 102 kDA, CaPK3 65 kDA, CaPK4 55 kDA, CaPK5 \u2013 39 kDA.\n\nGIKS3 alone control: peak corresponding to the protein with a mass of 120 kDa was detected.\nGIKS3+ CaPK1: peaks corresponding to protein with masses of 45 kDa, and 120 kDa were detected.\nGIKS3+ CaPK2: peak corresponding to protein with a mass of 222 kDa was detected.\nGIKS3+ CaPK3: peaks corresponding to proteins with masses of 65 kDa, 120 kDa, and 185 kDa were detected. \nGIKS3+ CaPK4: peaks corresponding to proteins with masses of 55 kDA, and 120 kDa were detected.\nGIKS3+ CaPK5: peaks corresponding to protein with masses of 39 kDA, 120 kDA, and 159 kDa were detected.\n\nIn the next experiment the researchers decided to test if the selected kinases can phosphorylate GIK3 and GIKS wild0type variant where the serine 25 was substituted to alanine (GIKS3-S25A). During the experiment, the proteins were incubated in the buffer: 50 mM Tris-Cl, 150 mM NaCl, 10 mM MgCl2, 2 mM CaCl2, 50 \u03bcm ATP supplemented with 1.5 \u03bcCi of [\u03b3-32P]ATP. The samples were incubated for 30 minutes at 37C and then SDS-PAGE was performed. Next, the phosphorylated proteins were detected with autoradiography. The results are described below:\n\nGIKS3-wt alone: Any band was detected.\nGIKS3 -S25/A alone: Any band was detected.\n\nGIKS3-wt + CaPK1: band corresponding to the protein with a mass of 45 kDa was detected.\nGIKS3-S25/A + CaPK1: band corresponding to the protein with a mass of 45 kDa was detected.\n\nGIKS3-wt + CaPK2: bands corresponding to the proteins with a mass of 60 kDa and 102 kDa were detected.\nGIKS3-S25/A + CaPK2: bands corresponding to the proteins with a mass of 60 kDa and 102 kDa were detected.\n\nGIKS3-wt + CaPK3: bands corresponding to the proteins with a mass of 60 kDa and 65 kDa were detected.\nGIKS3-S25/A + CaPK3: band corresponding to the protein with a mass of 65 kDa was detected.\n\nGIKS3-wt + CaPK4: bands corresponding to the proteins with a mass of 55 kDa and 60 kDa were detected.\nGIKS3-S25/A + CaPK4: band corresponding to the protein with a mass of 55 kDa was detected.\n\nGIKS3-wt + CaPK5: Any band was detected.\nGIKS3-S25/A + CaPK5: Any band was detected.\n\nIn the last exams the GIKS3 was incubated with tested kinases in the buffer without radoactive ATP and the activity of the GIKS3 enzyme was tested by measuring the conversion of molecule A to molecule over 5 minutes. Based on the results the rate of conversion was calculated the results are provided below:\n\nGIKS3-wt alone: rate of conversion 0 mmol/min\nGIKS3 -S25/A alone: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK1: rate of conversion 0 mmol/min\nGIKS3-S25/A + CaPK1: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK2: rate of conversion 3 mmol/min\nGIKS3-S25/A + CaPK2: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK3: rate of conversion 3 mmol/min\nGIKS3-S25/A + CaPK3: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK4: rate of conversion 3 mmol/min\nGIKS3-S25/A + CaPK4: rate of conversion 0 mmol/min\n\nGIKS3-wt + CaPK5: rate of conversion 0 mmol/min\nGIKS3-S25/A + CaPK5: rate of conversion 0 mmol/min\n\n\nBased on the provided data choose the correct answer:\n\nAnswer Choices:\nA. CaPK2 and CaPK3 can phosphorylate GIKS3 on serine 25. CaPK4 does not interact with GIKS3 and CaPK1 does not interact with GIKS3.\nB. Only CaPK3 and CaPK4 can activate GIKS3. The complex between CaPK4 and GIKS3 was not detected in the SEC-MALS experiment.\nC. None of the above is correct.\nD. CaPK2 CaPK3 can phosphorylate GIKS3 on serine 25. CaPK1 and CaPK4 do not interact with GIKS3.\nE. Only CaPK1, CaPK2, CaPK3 and CaPK4  are active kinases. CaPK2 and CaPK3 can phosphorylate GIKS3 on serine 25.\nF. Only CaPK3 and CaPK2 can phosphorylate GIKS3 on serine 25. CaPK4 does not interact with GIKS3 but CaPK1 interacts with GIKS3.\nG. Only CaPK3 and CaPK4 can activate GIKS3. Only CaPK2 interacts with GIKS3.\nH. Only CaPK3 and CaPK4 can activate GIKS3. The complex between CaPK4 and GIKS3 was detected in the SEC-MALS experiment.\nI. Only CaPK2 and CaPK3 can phosphorylate GIKS3 on serine 25."
        }
      ],
      "reasoning_effort": "medium",
      "response_format": {
        "type": "json_schema",
        "json_schema": {
          "name": "answer",
          "strict": true,
          "schema": {
            "type": "object",
            "properties": {
              "answer": {
                "type": "string"
              },
              "answer_letter": {
                "type": "string",
                "enum": [
                  "A",
                  "B",
                  "C",
                  "D",
                  "E",
                  "F",
                  "G",
                  "H",
                  "I"
                ]
              }
            },
            "required": [
              "answer",
              "answer_letter"
            ],
            "additionalProperties": false
          }
        }
      },
      "usage": {
        "include": true
      }
    },
    "response": {
      "id": "gen-1762211263-BrSMFQdENXYEtfUiasEG",
      "choices": [
        {
          "finish_reason": "stop",
          "index": 0,
          "logprobs": null,
          "message": {
            "content": "{\"answer\":\"C\\n\\nReasoning (brief):\\n- Activation (enzyme assay): CaPK2, CaPK3, and CaPK4 activate wild-type GIKS3 but not the S25A mutant \u2192 these three phosphorylate S25 (phosphorylation of S25 is required for activity).\\n- Autoradiography: CaPK3 and CaPK4 label only WT GIKS3 (not S25A) so they specifically target S25; CaPK2 labels both WT and S25A (it phosphorylates additional sites) but still activates only WT, consistent with phosphorylation of S25 as well. CaPK1 autophosphorylates but does not label GIKS3; CaPK5 does not phosphorylate GIKS3.\\n- SEC-MALS (interaction): stable complexes detected with CaPK2 and CaPK3 (222 and 185 kDa peaks); no stable complex detected with CaPK4 (55 + 120 kDa peaks only), CaPK1 shows no complex, and CaPK5 shows a complex (159 kDa) despite lack of phosphorylation.\\nNo answer choice correctly matches all these observations, so C is correct.\",\"answer_letter\":\"C\"}",
            "refusal": null,
            "role": "assistant",
            "annotations": null,
            "audio": null,
            "function_call": null,
            "tool_calls": null,
            "reasoning": "**Analyzing GIKS3 dimerization**\n\nI need to parse the data to summarize findings about the GIKS3 enzyme. It has a mass of 60 kDa but shows a peak of 120 kDa alone, indicating it forms a dimer. When combined with CaPK1, there\u2019s no complex formed. However, with CaPK2 and CaPK3, complexes form at 222 kDa and 185 kDa respectively, suggesting possible 1:1 interactions. This indicates GIKS3 can interact with CaPK2 and CaPK3 to create distinct complexes.**Exploring interactions with CaPKs**\n\nThe data shows that with CaPK3, a complex of a GIKS3 dimer and one CaPK3 monomer is formed at 185 kDa. However, when tested with CaPK4, only individual peaks for GIKS3 and the CaPK4 monomer appear, indicating no interaction. For CaPK5, a complex is detected, but autoradiography shows no phosphorylated bands for it, meaning it doesn't activate GIKS3. The phosphorylation results show CaPK1 autophosphorylates but doesn't interact with GIKS3, confirmed by SEC results.**Evaluating GIKS3 and CaPK2 phosphorylation**\n\nBoth GIKS3 and CaPK2 are phosphorylated. The GIKS3-S25A mutant still shows bands at 60 kDa, indicating it has mass similar to the wild type. When GIKS3-S25A is tested with CaPK2, bands corresponding to 60 kDa and 102 kDa are detected, suggesting CaPK2 can phosphorylate GIKS3 even with the S25 mutation. However, GIKS3's activity relies on S25, and the activity assay shows that while phosphorylation occurs, it does not activate the enzyme, likely affecting other residues instead.**Assessing phosphorylation specificity**\n\nThe question centers on identifying the kinase that phosphorylates serine 25 while activating wild-type GIKS3 but not the S25A mutant. Although autoradiography shows both variants with a 60 kDa band when phosphorylated by CaPK2, the activity assay reveals that only the wild type is activated. This suggests that while CaPK2 phosphorylates S25 in the wild type, it also targets other sites in the mutant. For CaPK3, autoradiography shows that it specifically phosphorylates serine 25, as the wild type shows bands at both 60 and 65 kDa, while the S25A only shows the 65 kDa band, confirming the specificity.**Determining kinase interactions and phosphorylation**\n\nThe analysis shows SEC confirmed complex formation between GIKS3 and CaPK3. CaPK4 phosphorylates wild-type GIKS3 but not the S25A mutant, and the activity assay supports this. The autoradiography also shows phosphorylation. However, CaPK5 interacts without phosphorylating. Based on this data, the kinases CaPK2, CaPK3, and CaPK4 can phosphorylate serine 25, while CaPK5 interacts but doesn't activate. Therefore, none of the provided options align correctly, leading to the conclusion that the right answer is C (None of the above).",
            "reasoning_details": [
              {
                "type": "reasoning.summary",
                "summary": "**Analyzing GIKS3 dimerization**\n\nI need to parse the data to summarize findings about the GIKS3 enzyme. It has a mass of 60 kDa but shows a peak of 120 kDa alone, indicating it forms a dimer. When combined with CaPK1, there\u2019s no complex formed. However, with CaPK2 and CaPK3, complexes form at 222 kDa and 185 kDa respectively, suggesting possible 1:1 interactions. This indicates GIKS3 can interact with CaPK2 and CaPK3 to create distinct complexes.**Exploring interactions with CaPKs**\n\nThe data shows that with CaPK3, a complex of a GIKS3 dimer and one CaPK3 monomer is formed at 185 kDa. However, when tested with CaPK4, only individual peaks for GIKS3 and the CaPK4 monomer appear, indicating no interaction. For CaPK5, a complex is detected, but autoradiography shows no phosphorylated bands for it, meaning it doesn't activate GIKS3. The phosphorylation results show CaPK1 autophosphorylates but doesn't interact with GIKS3, confirmed by SEC results.**Evaluating GIKS3 and CaPK2 phosphorylation**\n\nBoth GIKS3 and CaPK2 are phosphorylated. The GIKS3-S25A mutant still shows bands at 60 kDa, indicating it has mass similar to the wild type. When GIKS3-S25A is tested with CaPK2, bands corresponding to 60 kDa and 102 kDa are detected, suggesting CaPK2 can phosphorylate GIKS3 even with the S25 mutation. However, GIKS3's activity relies on S25, and the activity assay shows that while phosphorylation occurs, it does not activate the enzyme, likely affecting other residues instead.**Assessing phosphorylation specificity**\n\nThe question centers on identifying the kinase that phosphorylates serine 25 while activating wild-type GIKS3 but not the S25A mutant. Although autoradiography shows both variants with a 60 kDa band when phosphorylated by CaPK2, the activity assay reveals that only the wild type is activated. This suggests that while CaPK2 phosphorylates S25 in the wild type, it also targets other sites in the mutant. For CaPK3, autoradiography shows that it specifically phosphorylates serine 25, as the wild type shows bands at both 60 and 65 kDa, while the S25A only shows the 65 kDa band, confirming the specificity.**Determining kinase interactions and phosphorylation**\n\nThe analysis shows SEC confirmed complex formation between GIKS3 and CaPK3. CaPK4 phosphorylates wild-type GIKS3 but not the S25A mutant, and the activity assay supports this. The autoradiography also shows phosphorylation. However, CaPK5 interacts without phosphorylating. Based on this data, the kinases CaPK2, CaPK3, and CaPK4 can phosphorylate serine 25, while CaPK5 interacts but doesn't activate. Therefore, none of the provided options align correctly, leading to the conclusion that the right answer is C (None of the above).",
                "format": "openai-responses-v1",
                "index": 0
              },
              {
                "type": "reasoning.encrypted",
                "data": "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",
                "id": "rs_0bc3ffb8c4b6793101690935c001788194b0d6f091340af03f",
                "format": "openai-responses-v1",
                "index": 0
              }
            ]
          },
          "native_finish_reason": "completed"
        }
      ],
      "created": 1762211263,
      "model": "openai/gpt-5-mini",
      "object": "chat.completion",
      "service_tier": null,
      "system_fingerprint": null,
      "usage": {
        "completion_tokens": 2498,
        "prompt_tokens": 1591,
        "total_tokens": 4089,
        "completion_tokens_details": {
          "accepted_prediction_tokens": null,
          "audio_tokens": null,
          "reasoning_tokens": 2240,
          "rejected_prediction_tokens": null,
          "image_tokens": 0
        },
        "prompt_tokens_details": {
          "audio_tokens": 0,
          "cached_tokens": 0
        },
        "cost": 0.00539375,
        "is_byok": false,
        "cost_details": {
          "upstream_inference_cost": null,
          "upstream_inference_prompt_cost": 0.00039775,
          "upstream_inference_completions_cost": 0.004996
        }
      },
      "provider": "OpenAI"
    }
  }
]